Pharmafile Logo
Pharmafocus logo
Advanced Search

liver disease

Showing 9 posts of 9 posts found.

Inventiva and Echosens collaborate to bring awareness to NASH and encourage screening for at-risk patients

June 8, 2023
Medical Education Echosens, Hepatology, Inventiva, liver disease, nash, non-alcoholic steatohepatitis

French clinical stage biopharmaceutical company Inventiva has announced a collaboration with US-based high-technology company Echosens to bring attention to, and …

News
versantis_square_nc_s-e1552579323179

Swiss biotech raises $16m for ‘undelivery mechanism’ in rare liver disease

September 18, 2019
Research and Development liver disease, versantis

A new method from Swiss Biotech Versantis promises to give far better immediate care and offer a treatment for a …

News
genentech_web

Roche’s Genentech to acquire inflammatory drug discovery firm Jecure

November 28, 2018
Research and Development, Sales and Marketing Genentech, Jecure, Roche, liver disease, nash, pharma

Roche’s subsidiary Genentech has finalised a definitive agreement to acquire Jecure, a US-based biotech which focuses on the discovery of …

News
fire-166421_960_720

Use of antacids found to promote liver disease

October 10, 2017
Manufacturing and Production, Research and Development biotech, drugs, liver disease, pharma, pharmaceutical

A study emerging from the University of California, San Diego, has revealed a correlation between the use of common acid …

News
768px-lambs_liver

Research unveils new drug targets for more effective treatment of liver disease

August 22, 2017
Manufacturing and Production, Research and Development life sciences, liver, liver cancer, liver disease, pharma, pharmaceuticals

Researchers from KTH The Royal Institute of Technology and Gothenburg University have identified new drug targets in the treatment of …

News

NICE approves first biliary cholangitis drug in 20 years

March 2, 2017
Sales and Marketing Intercept Pharmaceuticals, intercept, liver disease, ocaliva, primary biliary cholangitis

Intercept Pharmaceuticals has announced that Ocaliva (obeticholic acid) has been approved by the National Institute for Health and Care Excellence …

News

New hepatitis C drug offers cure for more patients

December 17, 2010
Research and Development, Sales and Marketing HCV, Janssen, hepatitis C, liver disease, telaprevir

A new treatment from Janssen which could help cure many more patients with hepatitis C has been submitted in Europe. …

News

Astellas signs stem cell partnership in liver disease

December 8, 2010
Research and Development Astellas, Cytori, Stem cells, liver disease, regenerative medicine

Astellas has teamed up with Cytori Therapeutics to develop a range of new stem cell treatments for liver disease and …

News

National clinical directors appointed

January 26, 2010
NHS, UK, appointment, dementia, elderly, liver disease

A trio of national clinical directors, whose areas of influence cover dementia, older people and liver disease, have been appointed …

News

Latest content

Regeneron and Sanofi’s sBLA for Dupixent accepted by FDA for priority review

September 26, 2023

Acesion Pharma raises €45m series B funding

September 26, 2023

CDC Advisory Committee recommends Pfizer’s RSV vaccine

September 25, 2023

FDA approves Eli Lilly and Boehringer Ingelheim’s Jardiance for chronic kidney disease treatment

September 25, 2023

FDA grants ODD to Nexcella’s NXC-201 as treatment for amyloid light chain amyloidosis

September 22, 2023